A transparent over-tube for endoscopic injection sclerotherapy and results in patients with esophageal varices

This report describes our data regarding repeated injection sclerotherapy using a newly designed over-tube. We treated 17 consecutive patients with esophageal varices, (3 acute, 6 elective and 8 prophylactic). An intravariceal injection of 5 per cent ethanolamine oleate was administered, using a new...

Full description

Saved in:
Bibliographic Details
Published in:Japanese journal of surgery 1987-07, Vol.17 (4), p.256-262
Main Authors: KITANO, S, IWANAGA, T, ISO, Y, KOYANAGI, N, SUGIMACHI, K
Format: Article
Language:English
Subjects:
Adult
Aged
Biological and medical sciences
Equipment Design
Esophageal and Gastric Varices - therapy
Esophagoscopes
Esophagoscopy - methods
Female
Fiber Optic Technology - instrumentation
Gastroenterology. Liver. Pancreas. Abdomen
Humans
Injections
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Male
Medical sciences
Middle Aged
Other diseases. Semiology
Sclerosing Solutions - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This report describes our data regarding repeated injection sclerotherapy using a newly designed over-tube. We treated 17 consecutive patients with esophageal varices, (3 acute, 6 elective and 8 prophylactic). An intravariceal injection of 5 per cent ethanolamine oleate was administered, using a newly designed transparent over-tube containing a second lumen for a flexible injection needle. This over-tube provides an easier, safer, shorter-in-time method of sclerosing esophageal varices. One of the 17 patients died as a result of liver failure associated with advanced cirrhosis and a concomitant hepatoma. Eradication of esophageal varices was attained in the remaining 16 patients, after an average of 5.0 injections over an average period of 5.8 weeks (range: 3-7 injections during 3-11 weeks). No complications, such as esophageal perforation or aspiration pneumonia were encountered. Recurrent variceal bleeding has not occurred during the 9 months follow-up.
ISSN:0047-1909
1436-2813
DOI:10.1007/BF02470697